Articles published by HighTide Therapeutics Inc.
EASD 2025 | HighTide Therapeutics Announces Oral Presentation of Phase 3 Data in Patients with Type 2 Diabetes
September 16, 2025
Via ACN Newswire
Tickers
HTTIF


EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies
September 10, 2024
Via ACN Newswire









Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.